Lysando AG Novel Antimicrobial Fusion Proteins EP3802620A1
Summary
The EPO published patent application EP3802620A1 on April 15, 2026, covering novel antimicrobial fusion proteins filed by Lysando AG. Inventors are Manfred Biebl and Martin Griessl, with the invention classified under C07K 19/00, C07K 14/47, and C12N 9/36. The application designates all major EPO member states including DE, FR, GB, IT, NL, ES, BE, CH, and others.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 34 changes logged to date.
What changed
The EPO published patent application EP3802620A1 for Lysando AG covering novel antimicrobial fusion proteins. The publication includes applicant Lysando AG, inventors Manfred Biebl and Martin Griessl, and designated states covering all major EPO member states. This is a patent application publication (Kind A1), indicating the application has been published with the search report. Parties in the antimicrobial therapeutics or biotech space should monitor this application for potential freedom-to-operate implications as the patent prosecution progresses.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NOVEL ANTIMICROBIAL FUSION PROTEINS
Publication EP3802620A1 Kind: A1 Apr 15, 2026
Applicants
Lysando AG
Inventors
BIEBL, Manfred, GRIESSL, Martin
IPC Classifications
C07K 19/00 20060101AFI20191206BHEP C07K 14/47 20060101ALI20191206BHEP C12N 9/36 20060101ALI20191206BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.